Reference ranges for the AKI risk biomarkers IGFBP7 and TIMP-2 are described.
We demonstrate that these markers are not elevated in chronic stable comorbid conditions.
The overall reference interval for [IGFBP7]∙[TIMP-2] in urine is 0.04–2.22 (ng/mL)2.